Jump to main content
Jump to site search

Issue 96, 2016
Previous Article Next Article

Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery

Author affiliations

Abstract

Multicomponent therapeutic platforms have been proposed to minimize dosage of each drug and reduce toxicity, leading to achieving a synergistic effect and maximizing therapeutic efficacy. In this work, a novel dual drug co-delivery system based on poly(acrylic acid) modified mesoporous silica nanoparticles (PAA-MSNs) for the combination of doxorubicin (DOX) and cisplatin (Pt@PAA-MSNDOX) was designed and synthesized. The cisplatin was conjugated with carboxyl groups to form pH-responsive crosslinking shells after the encapsulation of DOX into the mesopores of MSNs. The obtained shell cross-linking nanocomposites were confirmed by various spectroscopic methods. The drug release behaviour of the dual drug loaded nanocomposites was pH sensitive. As a result, 70.0% of Pt(II) and 79.9% of DOX were released within 144 h at pH 5.5 with 0.9% NaCl, while only 15.9% of Pt(II) and 25.3% of DOX was released at pH 7.4. Confocal fluorescence microscopy revealed that Pt@PAA-MSNDOX nanocomposites effectively delivered and released DOX to the nuclei of HeLa (human cervical carcinoma) cells. An in vitro cell assay demonstrated the high biocompatibility of PAA-MSN and increased cytotoxicity of Pt@PAA-MSNDOX nanocomposites in both HeLa and A357 (human melanoma cells) tumor cells with respect to free single drug or single drug loaded nanoparticles at the same dosage. This unique drug co-delivery system using an anticancer drug as a cross-linking linkage suggests a promising application in multi-drug delivery for combination cancer therapy.

Graphical abstract: Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery

Back to tab navigation

Supplementary files

Article information


Submitted
05 Jul 2016
Accepted
25 Sep 2016
First published
28 Sep 2016

RSC Adv., 2016,6, 94160-94169
Article type
Paper

Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery

H. Li, H. Yu, C. Zhu, J. Hu, M. Du, F. Zhang and D. Yang, RSC Adv., 2016, 6, 94160 DOI: 10.1039/C6RA17213J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.


Social activity

Search articles by author

Spotlight

Advertisements